YD Bio Stock (NASDAQ:YDES)
Previous Close
$3.87
52W Range
$1.70 - $25.00
50D Avg
$2.74
200D Avg
$6.94
Market Cap
$339.99M
Avg Vol (3M)
$142.31K
Beta
-0.12
Div Yield
-
YDES Company Profile
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.